Continued operational progress and strengthened financial position provides capital for key value inflection points and continued investment in leading technology platform Full data expected in Q1 2023 for BEN-2293 Phase IIa clinical study; a potential treatment for atopic dermatitis and a topical, best-in-class PanTrk inhibitor Collaboration extended with AstraZeneca to four disease areas, now with … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today announced that preclinical studies characterizing the progression of cardiac dysfunction and mortality in a BAG3 haploinsufficiency mouse model of dilated cardiomyopathy will be featured in … [Read more…]
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the third quarter 2022 after the market closes on Wednesday, November 2, 2022. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, November … [Read more…]
Institutional Shareholder Services joins Glass Lewis in recommending a vote FOR the Redomicile resolution ISS cites potential for improved capital raising ability and commercialization efficiencies for the Company’s lead product candidate, zanidatamab To vote, contact Kingsdale Advisors at 1-855-476-7981 (within North America) or at 1-416-867-2272 (outside North America), or at contactus@kingsdaleadvisors.com VANCOUVER, British Columbia & … [Read more…]
The inaugural event honoured cancer survivors and raised funds for the Magic Castle TORONTO–(BUSINESS WIRE)–#BeWellAdvised–The inaugural ONE LIFE Gala in support of the Princess Margaret Cancer Centre announces it has raised over $400,000 for the Magic Castle, a play area for children of cancer patients undergoing treatment. Presented by the CI Assante Wealth Management Circle … [Read more…]
HONG KONG–(BUSINESS WIRE)–Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the Grand Court of the Cayman Islands (“Grand Court”) on September 22, 2022 (the “Order”) appointing Margot … [Read more…]
Upon satisfaction of certain closing conditions including approval by Exicure stockholders, existing investor CBI USA, Inc. will purchase an aggregate of 3,400,000 shares of common stock for an aggregate purchase price of $5.4 million, which would result in CBI obtaining a controlling stake in Exicure Exicure to reduce its workforce by approximately 66%, along with … [Read more…]
ALPHARETTA, Ga.–(BUSINESS WIRE)–On July 8, 2022, Cytometry Specialists, Inc. d/b/a CSI Laboratories (“CSI”), learned that it had been the victim of a phishing attack after a single employee’s individual mailbox was compromised. Upon learning of the incident, CSI immediately took steps to isolate and secure its systems and investigate the incident. CSI believes the access … [Read more…]
WINNIPEG, Manitoba–(BUSINESS WIRE)–#GBW22–Today marks the beginning of Global Biotech Week which aims to increase awareness of Manitoba’s $10.4 billion biotech industry, its global potential, policymakers, influencers, and the public. Each year, biotech leaders, researchers, and industry stakeholders in Manitoba join in highlighting the success stories and promoting the various career pathways in bioscience. “Manitoba has … [Read more…]
NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company’s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company’s third … [Read more…]
